<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-YHKLLNOU</identifier><date>2012</date><creator>Štrukelj, Borut</creator><relation>documents/doc/Y/URN_NBN_SI_doc-YHKLLNOU_001.htm</relation><relation>documents/doc/Y/URN_NBN_SI_doc-YHKLLNOU_001.pdf</relation><relation>documents/doc/Y/URN_NBN_SI_doc-YHKLLNOU_001.txt</relation><format format_type="issue">2</format><format format_type="volume">63</format><format format_type="type">article</format><format format_type="extent">str. 112-115</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3244401</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-YHKLLNOU</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">cepljenje</subject><subject language_type_id="slv">konjugirana cepiva</subject><subject language_type_id="slv">Prevenar</subject><subject language_type_id="slv">Synflorix</subject><subject language_type_id="slv">vnetje srednjega ušesa</subject><title>Novel vaccines against otitis media</title><title>Sodobna cepiva proti vnetju srednjega ušesa</title></Record>